Found: 115
Select item for more details and to access through your institution.
Intra-atrial re-entrant tachycardia in patients with congenital heart disease: factors associated with disease severity.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Predictors of acute inefficacy and the radiofrequency energy time required for cavotricuspid isthmus-dependent atrial flutter ablation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Single intracoronary injection of encapsulated antagomir-92a promotes angiogenesis and prevents adverse infarct remodeling.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Metastatic extraneural glioblastoma diagnosed with molecular testing.
- Published in:
- Oncologist, 2024, v. 29, n. 9, p. 811, doi. 10.1093/oncolo/oyae115
- By:
- Publication type:
- Article
Decentralized Clinical Trials in Early Drug Development--A Framework Proposal.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 3, p. 190, doi. 10.36401/JIPO-23-33
- By:
- Publication type:
- Article
Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 124, doi. 10.1007/s10637-021-01184-5
- By:
- Publication type:
- Article
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 3, p. 829, doi. 10.1007/s10637-020-01043-9
- By:
- Publication type:
- Article
Phase 1 study of 2 high dose intensity schedules of the pan-Notch inhibitor crenigacestat (LY3039478) in combination with prednisone in patients with advanced or metastatic cancer.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 193, doi. 10.1007/s10637-020-00944-z
- By:
- Publication type:
- Article
Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1570, doi. 10.1007/s10637-020-00910-9
- By:
- Publication type:
- Article
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 271, doi. 10.1007/s10637-018-0627-4
- By:
- Publication type:
- Article
Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedules.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 1, p. 76, doi. 10.1007/s10637-018-0602-0
- By:
- Publication type:
- Article
Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 3, p. 476, doi. 10.1007/s10637-017-0546-9
- By:
- Publication type:
- Article
A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 710, doi. 10.1007/s10637-015-0241-7
- By:
- Publication type:
- Article
Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 2, p. 357, doi. 10.1007/s10637-014-0192-4
- By:
- Publication type:
- Article
Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 670, doi. 10.1007/s10637-014-0082-9
- By:
- Publication type:
- Article
Management of Heart Failure with Reduced Ejection Fraction after ESC 2016 Heart Failure Guidelines: The Linx Registry.
- Published in:
- ESC Heart Failure, 2020, v. 7, n. 1, p. 25, doi. 10.1002/ehf2.12567
- By:
- Publication type:
- Article
ERRATUM: Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity.
- Published in:
- Scientific Reports, 2015, p. 8179, doi. 10.1038/srep08179
- By:
- Publication type:
- Article
Rapid SARS-CoV-2 Inactivation in a Simulated Hospital Room Using a Mobile and Autonomous Robot Emitting Ultraviolet-C Light.
- Published in:
- 2022
- By:
- Publication type:
- Journal Article
Public and patient involvement: a survey on knowledge, experience and opinions among researchers within a precision oncology European project.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11262-x
- By:
- Publication type:
- Article
Intra-atrial re-entrant tachycardia in congenital heart disease: types and relation of isthmus to atrial voltage.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Entrainment from the para-Hisian region for differentiating atrioventricular node reentrant tachycardia from orthodromic atrioventricular reentrant tachycardia.
- Published in:
- EP: Europace, 2008, v. 10, n. 10, p. 1205, doi. 10.1093/europace/eun249
- By:
- Publication type:
- Article
Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to Humans, Kenya, 2022-2023.
- Published in:
- Emerging Infectious Diseases, 2024, v. 30, n. 3, p. 581, doi. 10.3201/eid3003.231488
- By:
- Publication type:
- Article
Extended Viral Shedding of MERS-CoV Clade B Virus in Llamas Compared with African Clade C Strain.
- Published in:
- Emerging Infectious Diseases, 2023, v. 29, n. 3, p. 585, doi. 10.3201/eid2903.220986
- By:
- Publication type:
- Article
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North‐Eastern Spain.
- Published in:
- Transboundary & Emerging Diseases, 2022, v. 69, n. 6, p. 3518, doi. 10.1111/tbed.14714
- By:
- Publication type:
- Article
Pigs are not susceptible to SARS‐CoV‐2 infection but are a model for viral immunogenicity studies.
- Published in:
- Transboundary & Emerging Diseases, 2021, v. 68, n. 4, p. 1721, doi. 10.1111/tbed.13861
- By:
- Publication type:
- Article
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 5, p. 995, doi. 10.3390/ijms18050995
- By:
- Publication type:
- Article
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 1, p. 79, doi. 10.1007/s11060-019-03337-2
- By:
- Publication type:
- Article
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 140, n. 2, p. 317, doi. 10.1007/s11060-018-2955-9
- By:
- Publication type:
- Article
Actionability classification of variants of unknown significance correlates with functional effect.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00420-w
- By:
- Publication type:
- Article
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab329
- By:
- Publication type:
- Article
Agreement and differential use of laboratory methods for the detection and quantification of SARS-CoV-2 in experimentally infected animals.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.1016201
- By:
- Publication type:
- Article
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 5, p. 811, doi. 10.1038/s41416-023-02356-1
- By:
- Publication type:
- Article
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 309, doi. 10.1038/s41416-023-02276-0
- By:
- Publication type:
- Article
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours.
- Published in:
- 2021
- By:
- Publication type:
- journal article
First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00369-w
- By:
- Publication type:
- Article
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00317-0
- By:
- Publication type:
- Article
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00240-w
- By:
- Publication type:
- Article
Predictors of positive electrophysiological study in patients with syncope and bundle branch block: PR interval and type of conduction disturbance.
- Published in:
- Clinical Cardiology, 2018, v. 41, n. 12, p. 1537, doi. 10.1002/clc.23079
- By:
- Publication type:
- Article
Cardiac resynchronization therapy is associated with a reduction in ICD therapies as it improves ventricular function.
- Published in:
- Clinical Cardiology, 2018, v. 41, n. 6, p. 803, doi. 10.1002/clc.22958
- By:
- Publication type:
- Article
Cryptogenic Stroke and Role of Loop Recorder.
- Published in:
- JAFIB: Journal of Atrial Fibrillation, 2014, v. 7, n. 4, p. 29
- By:
- Publication type:
- Article
New clinical trial designs in the era of precision medicine.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 3, p. 549, doi. 10.1002/1878-0261.12465
- By:
- Publication type:
- Article
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 9, p. 1263, doi. 10.1002/1878-0261.12099
- By:
- Publication type:
- Article
Optimal design of trials to demonstrate the utility of genomically-guided therapy: Putting Precision Cancer Medicine to the test.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 5, p. 940, doi. 10.1016/j.molonc.2014.06.014
- By:
- Publication type:
- Article
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers.
- Published in:
- Oncologist, 2024, v. 29, n. 6, p. 493, doi. 10.1093/oncolo/oyae011
- By:
- Publication type:
- Article
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
- Published in:
- Oncologist, 2024, v. 29, n. 4, p. e514, doi. 10.1093/oncolo/oyad338
- By:
- Publication type:
- Article
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1100, doi. 10.1093/oncolo/oyad158
- By:
- Publication type:
- Article